Free Trial

Congress Asset Management Co. Purchases 33,373 Shares of Balchem Co. (NASDAQ:BCPC)

Balchem logo with Basic Materials background

Congress Asset Management Co. increased its holdings in Balchem Co. (NASDAQ:BCPC - Free Report) by 12.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 301,440 shares of the basic materials company's stock after purchasing an additional 33,373 shares during the quarter. Congress Asset Management Co. owned 0.93% of Balchem worth $53,053,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in BCPC. Allspring Global Investments Holdings LLC increased its stake in Balchem by 1.9% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 83,221 shares of the basic materials company's stock valued at $12,895,000 after buying an additional 1,553 shares during the period. Norden Group LLC acquired a new position in Balchem during the 1st quarter valued at $430,000. Commonwealth Equity Services LLC raised its stake in Balchem by 4.9% during the 1st quarter. Commonwealth Equity Services LLC now owns 14,722 shares of the basic materials company's stock valued at $2,281,000 after purchasing an additional 691 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Balchem by 21.8% in the 1st quarter. BNP Paribas Financial Markets now owns 37,117 shares of the basic materials company's stock valued at $5,751,000 after buying an additional 6,652 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its stake in shares of Balchem by 53.5% in the 1st quarter. Janney Montgomery Scott LLC now owns 2,977 shares of the basic materials company's stock valued at $461,000 after buying an additional 1,038 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.

Analyst Ratings Changes

BCPC has been the subject of a number of recent analyst reports. HC Wainwright increased their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a "buy" rating in a research report on Wednesday, July 31st. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a report on Monday.

Get Our Latest Stock Analysis on BCPC

Balchem Trading Down 0.9 %

Shares of NASDAQ BCPC traded down $1.55 during mid-day trading on Thursday, hitting $167.33. The company's stock had a trading volume of 94,888 shares, compared to its average volume of 106,994. The stock has a market cap of $5.43 billion, a price-to-earnings ratio of 47.32, a price-to-earnings-growth ratio of 5.43 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. Balchem Co. has a one year low of $114.97 and a one year high of $186.03. The company's fifty day simple moving average is $171.75 and its 200-day simple moving average is $162.75.

About Balchem

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

See Also

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

→ I hate to say I told you so (From WealthPress) (Ad)

Should you invest $1,000 in Balchem right now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines